| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LENSAR, Inc. | Director | Common Stock | 42.6K | $189K | $4.43 | May 7, 2024 | Direct |
| GERON CORP | Director | Common Stock | 26.2K | $59.8K | $2.28 | Aug 24, 2023 | By Spouse |
| GERON CORP | Director | Common Stock | 7.41K | $16.9K | $2.28 | Aug 24, 2023 | Direct |
| GERON CORP | Director | Stock Option (right to buy) | 180K | May 9, 2024 | Direct | ||
| Inhibikase Therapeutics, Inc. | Director | Stock Option (right to buy) | 40K | Jun 24, 2022 | Direct | ||
| LENSAR, Inc. | Director | Stock Option (Right to Buy) | 33.2K | May 25, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GERN | GERON CORP | May 9, 2024 | 1 | $0 | 4 | May 10, 2024 | Director |
| LNSR | LENSAR, Inc. | May 7, 2024 | 1 | $0 | 4 | May 9, 2024 | Director |
| GERN | GERON CORP | Aug 24, 2023 | 2 | $30.1K | 4 | Aug 24, 2023 | Director |
| GERN | GERON CORP | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| LNSR | LENSAR, Inc. | May 25, 2023 | 2 | $0 | 4 | May 30, 2023 | Director |
| IKT | Inhibikase Therapeutics, Inc. | Jun 24, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
| LNSR | LENSAR, Inc. | May 25, 2022 | 2 | $0 | 4 | May 27, 2022 | Director |
| GERN | GERON CORP | May 10, 2022 | 1 | $0 | 4 | May 11, 2022 | Director |
| IKT | Inhibikase Therapeutics, Inc. | Jun 25, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Director |
| LNSR | LENSAR, Inc. | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |
| GERN | GERON CORP | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |